Richard Haynes joins Protas as Chief Scientist
Protas announces the appointment of Professor Richard Haynes MBE DM FRCP to its Executive Team.
The latest in smarter trials
As a not-for-profit, our mission is to enable whole-system change in clinical trials. This means sharing our approach and knowledge with our community. From news about Protas, our partnerships and trials, to advice and guidance, discover more about our world.
Protas achieves ISO 27001 certification for information security
The UKAS accredited certification is the international standard for information security management systems.
Protas partners with Duke Clinical Research Institute
The partnership aims to transform the quality, accessibility and affordability of randomised clinical trials for common health conditions.
Protas signs strategic partnership with Moderna
Moderna is a leading biotechnology company pioneering mRNA. Its mission is to deliver the greatest possible impact to people.
Protas IT contract awarded to Slalom
Protas awards the contract to develop and operate a unified clinical trials management platform to Slalom.
Protas signs strategic collaboration with Regeneron
Protas and Regeneron, the leading biotechnology company, announce a strategic, long-term collaboration.
Protas announces grant funding from Flu Lab
Protas has announced a £5 million grant from Flu Lab, a charitable organisation fuelling bold approaches to defeat influenza.
Protas appoints Beth Thompson to its board
Protas is pleased to announce the appointment of Dr Beth Thompson MBE to its Board of Directors.
Protas receives grant from venture capital firm GV
The £5m grant recognises the unique ability of Protas to deliver better clinical trials.
Protas receives support from Schmidt Futures
Protas has been awarded a grant by the philanthropic initiative founded by Eric and Wendy Schmidt.
Protas interviewed by The Lancet for new Research Focus
The medical journal has published an in-depth article exploring Protas’ work and mission.
Protas welcomes the Good Clinical Trials Collaborative
Protas becomes the new host organisation for the Good Clinical Trials Collaborative.